Lilly (LLY) expects to launch five new medicines by 2023 end including Mounjaro for type II diabetes (already launched) and donanemab for early Alzheimer's disease.
Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy are part of The Zacks top Analyst Blog.
Three Motley Fool contributors have identified stocks to buy and hold forever. Here's why they chose Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Eli Lilly): If you're planning to hold a stock forever, then you need to be comfortable with its growth potential.